why choose us

First received: November 21, 2024

Clinical Trial: Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)

Study Type: INTERVENTIONAL


Official Title: Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

Brief Summary: Iron deficiency (ID) affects about 25% of the global population, presenting with symptoms of fatigue, weakness, and impaired cognitive function.Its prevalence is lower in developed regions, due to fortified foods, supplements, and better healthcare.In contrast, ID is more common in resource-limited countries, where diets lack iron, healthcare is less accessible, and infections like malaria and hookworm are more prevalent.In Asia, ID rates vary widely, influenced by dietary habits, socioeconomic factors, and…

Read more